Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity

Biochemical and Biophysical Research Communications

Volumn 350, Issue 1, 2006, Pages 162-168

  Fu, Jinrong ^a   Lin, Guosheng ^a   Zeng, Bin ^a   Wu, Zhiwei ^a   Wu, Yanxia ^a   Chu, Honggang ^a   Qin, Gangjian ^b   Liang, Gong ^c   Li, Jinan ^d   Gan, Xiang ^e   Yu, Xiaolan ^e   Li, Chunhua ^e   Liu, Dongxu ^d,e  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HUBEI UNIVERSITY   (China)

Author keywords

C1 inhibitor; C3; Cardiomyocyte; Complement; Hemolysis; Ischemia; Reperfusion

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HEART CELL CULTURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IN VITRO STUDY; MALE; MUSCLE CELL; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

ANIMALS; CELL HYPOXIA; CELL LINE; CHICKENS; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C3; ERYTHROCYTES; FEMALE; HEMOLYSIS; MALE; MYOCARDIAL REPERFUSION INJURY; OXYGEN; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33749063415     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.023     Document Type: Article

References (33)

1. Farb A., Kolodgie F.D., Jenkins M., and Virmani R. Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J. Am. Coll. Cardiol. 21 (1993) 1245-1253
2. Hearse D.J., and Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc. Res. 26 (1992) 101-108
3. Weiser M.R., Gibbs S.A., Valeri C.R., Shepro D., and Hechtman H.B. Anti-selectin therapy modifies skeletal muscle ischemia and reperfusion injury. Shock 5 (1996) 402-407
4. Maroko P.R., Carpenter C.B., Chiariello M., Fishbein M.C., Radvany P., Knostman J.D., and Hale S.L. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest. 61 (1978) 661-670
5. Entman M.L., Michael L., Rossen R.D., Dreyer W.J., Anderson D.C., Taylor A.A., and Smith C.W. Inflammation in the course of early myocardial ischemia. Faseb. J. 5 (1991) 2529-2537
6. Lagrand W.K., Niessen H.W., Wolbink G.J., Jaspars L.H., Visser C.A., Verheugt F.W., Meijer C.J., and Hack C.E. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95 (1997) 97-103
7. Rossen R.D., Swain J.L., Michael L.H., Weakley S., Giannini E., and Entman M.L. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury. Circ. Res. 57 (1985) 119-130
8. Horstick G., Heimann A., Gotze O., Hafner G., Berg O., Boehmer P., Becker P., Darius H., Rupprecht H.J., Loos M., Bhakdi S., Meyer J., and Kempski O. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 95 (1997) 701-708
9. de Zwaan C., Kleine A.H., Diris J.H., Glatz J.F., Wellens H.J., Strengers P.F., Tissing M., Hack C.E., van Dieijen-Visser M.P., and Hermens W.T. Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur. Heart J. 23 (2002) 1670-1677
10. Buerke M., Schwertz H., Seitz W., Meyer J., and Darius H. Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J. Immunol. 167 (2001) 5375-5380
11. Buerke M., Murohara T., and Lefer A.M. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91 (1995) 393-402
12. Collard C.D., Vakeva A., Bukusoglu C., Zund G., Sperati C.J., Colgan S.P., and Stahl G.L. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96 (1997) 326-333
13. Collard C.D., Bukusoglu C., Agah A., Colgan S.P., Reenstra W.R., Morgan B.P., and Stahl G.L. Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells. Am. J. Physiol. 276 (1999) C450-C458
14. Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., Buras J.A., Meri S., and Stahl G.L. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156 (2000) 1549-1556
15. Kirschfink M., and Nurnberger W. C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application. Mol. Immunol. 36 (1999) 225-232
16. Caliezi C., Wuillemin W.A., Zeerleder S., Redondo M., Eisele B., and Hack C.E. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol. Rev. 52 (2000) 91-112
17. Horstick G., Berg O., Heimann A., Gotze O., Loos M., Hafner G., Bierbach B., Petersen S., Bhakdi S., Darius H., Horstick M., Meyer J., and Kempski O. Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation 104 (2001) 3125-3131
18. Buerke M., Prufer D., Dahm M., Oelert H., Meyer J., and Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J. Pharmacol. Exp. Ther. 286 (1998) 429-438
19. Akita N., Nakase H., Kaido T., Kanemoto Y., and Sakaki T. Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 52 (2003) 395-400
20. De Simoni M.G., Storini C., Barba M., Catapano L., Arabia A.M., Rossi E., and Bergamaschini L. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 232-239
21. Nielsen E.W., Mollnes T.E., Harlan J.M., and Winn R.K. C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand. J. Immunol. 56 (2002) 588-592
22. Zheng X., Feng B., Chen G., Zhang X., Li M., Sun H., Liu W., Vladau C., Liu R., Jevnikar A.M., Garcia B., Zhong R., and Min W.P. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am. J. Transplant. 6 (2006) 2099-2108
23. Pinckard R.N., O'Rourke R.A., Crawford M.H., Grover F.S., McManus L.M., Ghidoni J.J., Storrs S.B., and Olson M.S. Complement localization and mediation of ischemic injury in baboon myocardium. J. Clin. Invest. 66 (1980) 1050-1056
24. Schafer H., Mathey D., Hugo F., and Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J. Immunol. 137 (1986) 1945-1949
25. Rossen R.D., Michael L.H., Kagiyama A., Savage H.E., Hanson G., Reisberg M.A., Moake J.N., Kim S.H., Self D., and Weakley S. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ. Res. 62 (1988) 572-584
26. Hill J.H., and Ward P.A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133 (1971) 885-900
27. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., and Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 105 (2000) 1363-1371
28. Williams J.P., Pechet T.T., Weiser M.R., Reid R., Kobzik L., Moore Jr. F.D., Carroll M.C., and Hechtman H.B. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86 (1999) 938-942
29. Jordan J.E., Montalto M.C., and Stahl G.L. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104 (2001) 1413-1418
30. Erdei A., Fust G., and Gergely J. The role of C3 in the immune response. Immunol. Today 12 (1991) 332-337
31. Yasojima K., Kilgore K.S., Washington R.A., Lucchesi B.R., and McGeer P.L. Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion. Circ. Res. 82 (1998) 1224-1230
32. Weisman H.F., Bartow T., Leppo M.K., Marsh Jr. H.C., Carson G.R., Concino M.F., Boyle M.P., Roux K.H., Weisfeldt M.L., and Fearon D.T. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249 (1990) 146-151
33. Frank M.M., and Fries L.F. The role of complement in inflammation and phagocytosis. Immunol. Today 12 (1991) 322-326